RMED Stock Statics Stock Price History Balance Sheet

RMED Stock Statics Stock Price History Balance Sheet

Ra Medical Systems was founded in 2002 to design, develop, and commercialize excimer lasers as tools for the treatment of vascular and dermatological diseases.

Pharos excimer laser system was launched in October 2004 and was used as a tool in the treatment of psoriasis, vitiligo, atopic dermatitis, and leukoderma.

The company sold these dermatological products and services in August 2021 to focus solely on the larger vascular business opportunity.

In May 2017, the DABRA laser and single-use catheter (together “DABRA”) received FDA 510(k) clearance in the U.S. for crossing chronic total occlusions in patients with symptomatic infrainguinal lower extremity vascular disease and has an intended use for ablating a channel in occlusive peripheral vascular disease.

DABRA is our minimally-invasive excimer laser and single-use catheter system that is used by physicians as a tool in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease, a form of peripheral artery disease, or PAD, both above- and below-the-knee.

Historical Stats and Price Data

Currency in USD

DateOpenHighLowClose*Adj Close**Volume
Mar 25, 20220.42000.42990.39000.40480.40483,272,229
Mar 25, 20220.42000.43000.39000.40000.40003,333,600
Mar 24, 20220.43000.46000.42000.44000.44006,456,300
Mar 23, 20220.52000.53000.49000.51000.51004,913,200
Mar 22, 20220.54000.54000.46000.51000.51005,758,000
Mar 21, 20220.50000.58000.49000.52000.52007,790,000
Mar 18, 20220.46000.50000.45000.47000.47003,799,400
Mar 17, 20220.43000.48000.42000.46000.46004,358,900
Mar 16, 20220.43000.45000.40000.42000.42003,014,600
Mar 15, 20220.44000.44000.41000.44000.44002,112,800
Mar 14, 20220.46000.50000.43000.44000.44004,611,500
Mar 11, 20220.39000.49000.38000.41000.41005,802,300
Mar 10, 20220.39000.42000.38000.40000.40002,976,200
Mar 09, 20220.40000.42000.38000.38000.38002,796,100
Mar 08, 20220.38000.39000.34000.38000.38004,408,400
Mar 07, 20220.39000.42000.38000.39000.39004,876,700
Mar 04, 20220.46000.50000.38000.42000.42006,124,500
Mar 03, 20220.50000.55000.44000.45000.45009,200,300
Mar 02, 20220.47000.59000.44000.49000.490012,969,800
Mar 01, 20220.44000.75000.41000.50000.500085,470,400
Feb 28, 20220.40000.48000.40000.43000.430010,001,400
Feb 25, 20220.38000.54000.37000.42000.420037,306,600
Feb 24, 20220.33000.36000.30000.35000.35003,792,400
Feb 23, 20220.35000.37000.34000.34000.34002,301,200
Feb 22, 20220.37000.38000.33000.36000.36003,656,000
Feb 18, 20220.41000.44000.38000.38000.38004,322,300
Feb 17, 20220.42000.44000.39000.39000.39004,300,300
Feb 16, 20220.40000.43000.39000.42000.42004,666,100
Feb 15, 20220.38000.41000.37000.40000.40005,246,500
Feb 14, 20220.40000.40000.36000.38000.38003,511,700
Feb 11, 20220.43000.44000.38000.40000.40008,273,300
Feb 10, 20220.38000.42000.38000.40000.40007,406,900
Feb 09, 20220.39000.40000.36000.39000.39008,213,200
Feb 08, 20220.36000.40000.35000.37000.370010,978,900
Feb 07, 20220.38000.38000.35000.36000.36009,362,500
Feb 04, 20220.33000.37000.33000.36000.360032,068,000
Feb 03, 20220.82000.84000.70000.70000.70001,559,600
Feb 02, 20220.92000.94000.87000.87000.8700405,600
Feb 01, 20220.95001.04000.86000.92000.9200416,400
Jan 31, 20221.00001.00000.94000.95000.9500231,600
RMED Stock Statics Stock Price History Balance Sheet

RMED Stock Statics Stock Price History Balance Sheet

Valuation Measures

Market Cap (intraday)11.48M
Enterprise Value-1.30M
Trailing P/EN/A
Forward P/EN/A
PEG Ratio (5 yr expected)N/A
Price/Sales (ttm)100.18
Price/Book (mrq)0.84
Enterprise Value/Revenue-59.23
Enterprise Value/EBITDA0.04

Trading Information

Stock Price History

Beta (5Y Monthly)1.65
52-Week Change-92.14%
S&P500 52-Week Change14.40%
52 Week High9.8200
52 Week Low0.3000
50-Day Moving Average0.6076
200-Day Moving Average2.4347

Share Statistics

Avg Vol (3 month)5.52M
Avg Vol (10 day)4.61M
Shares Outstanding26.33M
Implied Shares Outstanding N/A
Float 6.53M
% Held by Insiders1.76%
% Held by Institutions2.62%
Shares Short (Mar 14, 2022)3.43M
Short Ratio (Mar 14, 2022)0.32
Short % of Float (Mar 14, 2022)13.19%
Short % of Shares Outstanding (Mar 14, 2022)13.04%
Shares Short (prior month Feb 14, 2022) 1.7M

Dividends & Splits

Forward Annual Dividend Rate N/A
Forward Annual Dividend Yield N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
5 Year Average Dividend YieldN/A
Payout Ratio0.00%
Dividend DateNov 16, 2020
Ex-Dividend DateN/A
Last Split Factor1:25
Last Split Date Nov 16, 2020

Financial Highlights

Fiscal Year

Fiscal Year EndsDec 30, 2021
Most Recent Quarter (mrq)Dec 30, 2021

Profitability

Profit Margin0.00%
Operating Margin (ttm)-133,027.27%

Management Effectiveness

Return on Assets (ttm)-67.15%
Return on Equity (ttm)-156.58%

Income Statement

Revenue (ttm)22k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)-99.60%
Gross Profit (ttm)-1.54M
EBITDA-28M
Net Income Avi to Common (ttm)-27.26M
Diluted EPS (ttm)-4.9590
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)15.04M
Total Cash Per Share (mrq)2.23
Total Debt (mrq)2.26M
Total Debt/Equity (mrq)16.56
Current Ratio (mrq)3.17
Book Value Per Share (mrq)2.03

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A

Follow us or bookmark us for more Bollywood news box office collection report celebrities trailers and promos

Join us on Facebook :

Join us on Twitter :

Leave a Reply

Your email address will not be published.